Education
About Us
Working with TipRanks
Follow Us
Sanofi SA (SNY)
:SNY
SNY Stock Chart & Stats
$49.73
-$0.67(-1.34%)
At close: 4:00 PM EST
$49.73
-$0.67(-1.34%)
Day’s Range― - ―
52-Week Range$44.62 - $60.12
Previous CloseN/A
Volume824.98K
Average Volume (3M)2.21M
Market Cap
$120.76B
Enterprise ValueN/A
Total Cash (Recent Filing)$15.36B
Total Debt (Recent Filing)$22.29B
Price to Earnings (P/E)12.3
Beta0.46
Next Earnings
Jan 29, 2026EPS Estimate
0.85Last Dividend Ex-Date
May 09, 2025Dividend Yield4.53%
Share Statistics
EPS (TTM)1.69
Shares Outstanding2,454,938,000
10 Day Avg. Volume2,169,279
30 Day Avg. Volume2,206,819
Financial Highlights & Ratios
PEG Ratio11.30
Price to Book (P/B)1.50
Price to Sales (P/S)2.63
P/FCF Ratio19.80
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$69.00Price Target Upside38.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
EarningsRobust sales from key products and new launches propelled earnings above expectations.
Financial PerformanceFree cash flow supports ongoing strategic investments and shareholder returns.
PartnershipsSanofi has partnered with Labcorp to make the INNOVANCE AT assay available at no cost.
Bears Say
Market CompetitionCompetition from alternatives of Dupixent could risk its market share being diminished.
Product SafetyQfitlia requires liver tests and monitoring for signs and symptoms of acute and recurrent gallbladder disease, indicating potential safety concerns.
Sanofi News
SNY FAQ
What was Sanofi SA’s price range in the past 12 months?
Sanofi SA lowest stock price was $44.62 and its highest was $60.12 in the past 12 months.
What is Sanofi SA’s market cap?
Sanofi SA’s market cap is $120.76B.
When is Sanofi SA’s upcoming earnings report date?
Sanofi SA’s upcoming earnings report date is Jan 29, 2026 which is in 48 days.
How were Sanofi SA’s earnings last quarter?
Sanofi SA released its earnings results on Oct 24, 2025. The company reported $1.692 earnings per share for the quarter, beating the consensus estimate of $1.578 by $0.114.
Is Sanofi SA overvalued?
According to Wall Street analysts Sanofi SA’s price is currently Undervalued.
Does Sanofi SA pay dividends?
Sanofi SA pays a Annually dividend of $2.212 which represents an annual dividend yield of 4.53%. See more information on Sanofi SA dividends here
What is Sanofi SA’s EPS estimate?
Sanofi SA’s EPS estimate is 0.85.
How many shares outstanding does Sanofi SA have?
Sanofi SA has 2,454,938,000 shares outstanding.
What happened to Sanofi SA’s price movement after its last earnings report?
Sanofi SA reported an EPS of $1.692 in its last earnings report, beating expectations of $1.578. Following the earnings report the stock price went up 4.281%.
Which hedge fund is a major shareholder of Sanofi SA?
Currently, no hedge funds are holding shares in SNY
Sanofi Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$69.00 (38.75% Upside)
$69.00 (38.75% Upside)
Blogger Sentiment
Bullish
SNY Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 1.6M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.0%
Last 30 Days ▲ 3.5%
Last 30 Days ▲ 3.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.14%
12-Months-Change
Fundamentals
Return on Equity
8.39%
Trailing 12-Months
Asset Growth
5.48%
Trailing 12-Months
Company Description
Sanofi SA
Sanofi (SNY) is a global healthcare company headquartered in France, focused on the research, development, manufacturing, and marketing of prescription pharmaceuticals, vaccines, and consumer healthcare products. Operating in various therapeutic areas, including diabetes, oncology, immunology, and rare diseases, Sanofi aims to improve patient outcomes through innovative therapies and vaccines. The company is also committed to addressing public health challenges by providing accessible healthcare solutions worldwide.
SNY Company Deck
SNY Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Sanofi demonstrated strong growth in Q3 driven by record-breaking sales, particularly from Dupixent and new product launches, along with significant advancements in vaccine innovation. However, there were challenges in vaccine sales due to competitive pressures and program discontinuations, as well as impacts from foreign exchange rates.View all SNY earnings summariesSNY Stock 12 Month Forecast
Average Price Target
$69.00
▲(38.75% Upside)
Technical Analysis
Ownership Overview
―
Insiders
3.87% Mutual Funds
4.72% Other Institutional Investors
91.15% Public Companies and
Individual Investors